ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
119.064,49
0,18%
S&P 500
5.816,93
-0,17%
US Dollar vs BRL
6,0945
-0,48%
Bitcoin
92.339,97
-2,27%
Brent Oil
80,565
-0,06%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. EXACT Sciences Corporation (EXAS)

  7. EXACT Sciences Corporation (EXAS) Notícias

EXAS

EXACT Sciences (EXAS)

EXACT Sciences Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EXAS
DataHoraFonteTítuloCódigoCompanhia
13/01/202511:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXASEXACT Sciences Corporation
12/01/202521:00Business WireExact Sciences Announces Preliminary Fourth Quarter 2024 ResultsNASDAQ:EXASEXACT Sciences Corporation
06/01/202518:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
06/01/202518:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
02/01/202508:00Business WireExact Sciences to Participate in J.P. Morgan Healthcare ConferenceNASDAQ:EXASEXACT Sciences Corporation
20/12/202418:30Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:EXASEXACT Sciences Corporation
26/11/202408:00Business WireExact Sciences to Participate in December Investor ConferencesNASDAQ:EXASEXACT Sciences Corporation
25/11/202419:35Business WireExact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024NASDAQ:EXASEXACT Sciences Corporation
13/11/202416:58Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:EXASEXACT Sciences Corporation
13/11/202415:00Business WireExact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid BiopsyNASDAQ:EXASEXACT Sciences Corporation
06/11/202408:09IH Market NewsTrump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time HighNASDAQ:EXASEXACT Sciences Corporation
05/11/202419:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXASEXACT Sciences Corporation
05/11/202418:05Business WireExact Sciences Announces Third-Quarter 2024 ResultsNASDAQ:EXASEXACT Sciences Corporation
05/11/202408:46IH Market NewsU.S. Index Futures Rise as Election Looms; Oil and Gold Prices SteadyNASDAQ:EXASEXACT Sciences Corporation
01/11/202407:00Business WireExact Sciences to Participate in November Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
27/10/202413:00Business WireExact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient EngagementNASDAQ:EXASEXACT Sciences Corporation
08/10/202414:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
08/10/202407:00Business WireExact Sciences Schedules Third Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
04/10/202407:00Business WireFDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer ScreeningNASDAQ:EXASEXACT Sciences Corporation
16/09/202403:35Business WireExact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024NASDAQ:EXASEXACT Sciences Corporation
28/08/202407:00Business WireExact Sciences to Participate in September Investor ConferencesNASDAQ:EXASEXACT Sciences Corporation
20/08/202408:00Business WireExact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence StudyNASDAQ:EXASEXACT Sciences Corporation
15/08/202408:00Business WireNew Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 BillionNASDAQ:EXASEXACT Sciences Corporation
31/07/202417:05Business WireExact Sciences Announces Second-Quarter 2024 ResultsNASDAQ:EXASEXACT Sciences Corporation
31/07/202417:05PR Newswire (US)TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing TechnologyNASDAQ:EXASEXACT Sciences Corporation
08/07/202407:00Business WireExact Sciences schedules second quarter 2024 earnings callNASDAQ:EXASEXACT Sciences Corporation
28/05/202407:00Business WireExact Sciences to Participate in June Investor ConferencesNASDAQ:EXASEXACT Sciences Corporation
25/05/202408:32Business WireASCO®: Exact Sciences bekräftigt mit mehreren Datenpräsentationen seine langfristige Vorreiterrolle in der Krebsfrüherkennung und bei der Verbesserung von BehandlungsergebnissenNASDAQ:EXASEXACT Sciences Corporation
24/05/202413:46Business WireExact Sciences démontre son leadership continu en matière de diagnostic précoce du cancer et d’amélioration des résultats pour les patients grâce à de multiples présentations de données à l’ASCO®NASDAQ:EXASEXACT Sciences Corporation
24/05/202407:05Business WireExact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®NASDAQ:EXASEXACT Sciences Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:EXAS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BRAV3
Brava Energia ON
BOV
PRIO3
PETRORIO ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
TELB4
TELEBRAS PN
BOV
IDIV
Dividend
BOV
FICT3
Fictor Alimentos ON
BOV
GPIV33
Gp Investments
BOV
FHER3
FER HERINGER ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
USIM5
USIMINAS PNA
BOV
GOLL4
GOL PN
BOV
AZEV4
AZEVEDO PN
BOV
IFCM3
Infracommerce Caxaas ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados